ENCell Co., Ltd. (KOSDAQ:456070)
11,060
-400 (-3.49%)
May 20, 2026, 3:30 PM KST
ENCell Company Description
Encell Co. Ltd. engages in the research, development, and manufacture of biopharmaceuticals.
It provides customized pharmaceutical development services, from early development stage to approval stage.
The company was founded in February 2018 and is headquartered in Seoul, South Korea.
ENCell Co., Ltd.
| Country | South Korea |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: 701, Youngdong Daero Seoul South Korea | |
| Phone | 82 2 6205 8050 |
Stock Details
| Ticker Symbol | 456070 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7456070002 |
| SIC Code | 8731 |